HLA DR15 (DR2) Immunosuppressive Response Association in Myelodysplastic Syndrome (MDS)
Also known as: DR15, Immunosuppressive Response, MDS, Myelodysplastic Syndrome
Use
Determine the presence of DR15 antigen.
Special Instructions
Not provided.
Limitations
Despite all the necessary precautions, there may be instances where the specimen is not suitable for testing, necessitating a recollection. The test has been developed and characterized by LabCorp, with performance metrics available, though it has not received FDA clearance or approval for diagnostic use. Variations in specimen collection and handling can significantly impact test accuracy and reliability.
Methodology
NGS (Targeted)
Biomarkers
No genes
Gene
LOINC Codes
- 6803-1 - HLA-DR15 Ql
- 49549-9 - Ref lab test method
Result Turnaround Time
3-7 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
7 mL
Minimum Volume
3 mL
Container
Lavender-top (EDTA) tube
Storage Instructions
Maintain blood specimen at room temperature.
Causes for Rejection
Hemolysis; clotted specimen; yellow-top (ACD) tube
Other tests from different labs that may be relevant